Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Long-term efficacy and safety results reported for lanthanum carbonate in chronic renal failure

June 17, 2003

Positive phase III topline results for Alprox-TD

June 17, 2003

Two series of ALK5 kinase inhibitors and their use described by GSK team

June 12, 2003

Ortho-McNeil scientists prepare and test novel PDE5 inhibitors

June 12, 2003

New PDE5 inhibitors in Schering-Plough development pipeline

June 11, 2003

Intranasal apomorphine enters new phase II study in erectile dysfunction

June 6, 2003

Influence of sildenafil on duodenal function and cirrhotic portal hemodynamics

June 4, 2003

Topiglan enters new phase II study for erectile dysfunction

June 4, 2003

No evidence of carcinogenicity in NexACT rat study

June 2, 2003

Phase II efficacy data reported for intranasal apomorphine in FSD

June 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
BIO 2026: Alternatives to funding orphan drugs
BioWorld
At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...